PCOS, Polycystic ovary syndrome
The brain tissue obtained was weighed and PBS was added in order to ensure a weight (g) to volume (mL) ratio of 1:9
The are a part of a class of medications know as incretin memetics which mimic incretin hormones (like GLP-1)
Owing to donor-to-donor variability associated with human samples, we repeated this protocol in additional sets of islets from humans that spanned a range of BMI, age and HbA1C%, and included donors of both sexes (Extended Data Table 2)
By increasing GLP-1 production or stimulating its release, this approach can complement existing therapies, such as GLP-1RAs and DPP-4 inhibitors, offering additional benefits while potentially reducing side effects
Mittelfristig (20272028): Erwartete FDA-Zulassung von Retatrutide als erste Triple-Agonist-Therapie